Annie Kennedy, chief of policy, advocacy, and patient engagement at the EveryLife Foundation for Rare Diseases, tells us why the Foundation sponsored The National Economic Burden of Rare Di
Novartis has joined a growing number of companies insisting that its workforce is double vaccinated against COVID-19 if they want to work at one of its sites.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
![[Image (From top left to bottom right): Avalere’s leadership team, including Kelly Brantley, Policy Practice Director; Sarah Alwardt, Healthcare Transformation Practice Director; Elizabeth Carpenter, President; Lance Grady, Market Access Practice Director; Miryam Frieder, Policy Practice Director; Rob Carter, Financial Services Practice Director.]](https://pharmaphorum.com/wp-content/uploads/2022/06/Pinehurst-PR-2.jpg)
